We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

Back to rankings

95 hedge funds and large institutions have $473M invested in AVANIR PHARMACEUTICALS, INC CL A in 2013 Q2 according to their latest regulatory filings, with 95 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $5.99M | Put options by funds: $3.33M

Holders
95
Holders Change
+95
Holders Change %
–
% of All Funds
3.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
95
Increased
–
Reduced
–
Closed
–
Calls
$5.99M
Puts
$3.33M
Net Calls
+$2.67M
Net Calls Change
+$2.67M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$99.9M +$74.7M +21,722,711 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$58.5M +$43.7M +12,716,873 New
ISL
3
Ingalls & Snyder LLC
New York
$51.6M +$38.6M +11,219,880 New
Wellington Management Group
4
Wellington Management Group
Massachusetts
$44.9M +$33.6M +9,768,545 New
BFA
5
BlackRock Fund Advisors
California
$27.1M +$20.2M +5,880,449 New
BIT
6
BlackRock Institutional Trust
California
$21.2M +$15.8M +4,600,002 New
TCM
7
TimesSquare Capital Management
New York
$19.6M +$14.6M +4,261,478 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$18.9M +$14.1M +4,115,372 New
BBA
9
Baker Bros. Advisors
New York
$16.5M +$12.3M +3,578,591 New
State Street
10
State Street
Massachusetts
$14.1M +$10.5M +3,068,897 New
AG
11
Artal Group
Luxembourg
$12.7M +$9.45M +2,750,000 New
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$10.6M +$7.91M +2,300,000 New
Northern Trust
13
Northern Trust
Illinois
$9.38M +$7.01M +2,039,954 New
BI
14
BVF Inc
California
$4.63M +$3.46M +1,006,053 New
CII
15
CR Intrinsic Investors
Connecticut
$4.13M +$3.09M +898,538 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$3.64M +$2.72M +790,644 New
Allianz Asset Management
17
Allianz Asset Management
Germany
$3.3M +$2.46M +717,100 New
Fidelity International
18
Fidelity International
Bermuda
$3.14M +$2.35M +682,400 New
WMSA
19
Weiss Multi-Strategy Advisers
New York
$2.94M +$2.2M +640,000 New
Barclays
20
Barclays
United Kingdom
$2.8M +$2.09M +609,288 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.78M +$2.08M +605,207 New
TCIM
22
TIAA CREF Investment Management
New York
$2.76M +$2.07M +600,827 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$2.46M +$1.84M +535,084 New
DCM
24
Driehaus Capital Management
Illinois
$2.38M +$1.78M +517,844 New
FIG
25
Fortress Investment Group
New York
$2.07M +$1.55M +450,000 New
1
2 3 4

AVNR Hedge Fund Activity: Q2 2013 in Review

95 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q2 2013, worth a combined $473M.

Buyers outnumbered sellers: 95 funds opened new AVNR positions and 0 closed out — a net gain of 95 holders — while 0 added to existing stakes and 0 trimmed.

  • 95 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $473M of AVANIR PHARMACEUTICALS, INC CL A stock for Q2 2013.
  • 95 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q2 2013 and 0 closed out, a net change of +95 holders.

Based on aggregated 13F filings for Q2 2013.